SCHEMBL16769886

SCHEMBL16769886

CCc1ccc(/C=C2\CN(S(=O)(=O)c3ccccc3)C/C(=C\c3ccc(CC)cc3)C2=O)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 2/20 0.48
▸ KMT2A Q03164 4/20 0.46
▸ ALDH1A1 P00352 4/20 0.46
▸ MAPT P10636 3/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ MDM2 Q00987 1/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TSHR P16473 1/20 0.45
▸ ACHE P22303 6/20 0.45
▸ BCHE P06276 2/20 0.45
▸ PTGS2 P35354 1/20 0.43
▸ PKM P14618 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ MITF O75030 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16755582 1.00 HSD11B1 (0.48) HSD11B1KMT2AALDH1A1MAPTMAPK1
SCHEMBL16755580 1.00 HSD11B1 (0.48) HSD11B1KMT2AALDH1A1MAPTMAPK1
SCHEMBL16755581 0.90 KMT2A (0.49) KMT2AALDH1A1MAPTMAPK1KDM4E
SCHEMBL16769875 0.90 KMT2A (0.49) KMT2AALDH1A1MAPTMAPK1KDM4E
SCHEMBL16755583 0.90 KMT2A (0.49) KMT2AALDH1A1MAPTMAPK1KDM4E
SCHEMBL19840306 0.88 ACHE (0.48) HSD11B1KMT2AALDH1A1LMNAMEN1
SCHEMBL16755587 0.88 ACHE (0.48) HSD11B1KMT2AALDH1A1LMNAMEN1
SCHEMBL15561380 0.88 ACHE (0.48) HSD11B1KMT2AALDH1A1LMNAMEN1
SCHEMBL16769879 0.88 KMT2A (0.47) KMT2AALDH1A1MAPTMAPK1KDM4E
SCHEMBL16755542 0.88 KMT2A (0.47) KMT2AALDH1A1MAPTMAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 — — US disclosed
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 — — US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 — — US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof COX15, HCCS, HMOX2 HSD11B1 766/4885KMT2A 2801/4885ALDH1A1 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback